جست‌وجوی استاد و پژوهشگر

James Floryمشاهده پروفایل

دانشیار

• Pharmacoepidemiology
• Diabetes Management
• Clinical Trials
• +۳ مورد دیگر

James Flory is an Associate Professor of Population Health Sciences at Weill Cornell Medical College , Cornell University. With an MD and MSCE from the University of Pennsylvania (2009) and a BA from Columbia University (2002), he specializes in pharmacoepidemiology and clinical research related to diabetes management, drug safety, and healthcare policy. Education: M.D., University of Pennsylvania School of Medicine, 2009 M.S.C.E., University of Pennsylvania School of Medicine, 2009 B.A., Columbia University, 2002 His research focuses on the intersection of diabetes pharmacology , cardiovascular risk , and health services research . He has contributed extensively to understanding drug safety (e.g., sulfonylureas, SGLT2 inhibitors, TRK inhibitors), medication adherence , and clinical decision-making in diabetes and oncology settings. His methodological work includes instrumental variable analysis , pragmatic trial design , and real-world data validation . James Flory's recent publications examine temperature-related diabetes complications , AI in clinical decision support , and policy impacts on medication utilization . His work combines epidemiological methods with health informatics to address critical questions in diabetic care , drug safety surveillance , and health equity .

• Occupational Health
• Public Health
• Environmental Health
• +۴ مورد دیگر

Lode Godderis is a full Professor at the KU Leuven Faculty of Medicine , affiliated with the Department of Public Health and Primary Care . He is actively involved in interdisciplinary research through memberships in institutions like the KU Leuven Brain Institute , Institute for Rare Diseases , and Cancer Institute . OCCUPATIONAL MEDICINE POC His research focuses on occupational health, epigenetics, and chronic pain mechanisms, particularly in post-cancer recovery and environmental exposure contexts. Recent projects include epigenetic studies in breast cancer survivors , workplace stress assessment frameworks , and exposome research for occupational disease prevention . Selected publications address critical areas such as carcinogenicity of fuel additives , mHealth interventions for musculoskeletal pain , and pandemic intelligence network design . Key collaborations span environmental health, oncology, and workplace well-being domains.

Iwan Barankayمشاهده پروفایل

دانشیار

• Behavioral Economics
• Political Economy
• Field Experiments
• +۳ مورد دیگر

Iwan Barankay is an Associate Professor of Management and Business Economics and Public Policy at the Wharton School, University of Pennsylvania . His research focuses on designing monetary and non-monetary incentives to enhance workplace productivity, cooperation, and health behavior through field experiments. Education: PhD, University of Warwick (2004) MSc, University of Warwick (1999) BSc, University of Lausanne (1998) Barankay’s work bridges behavioral economics with practical applications in personnel economics and health incentives. Through randomized control trials, he investigates how financial and social incentives impact medication adherence, physical activity, and workplace dynamics. His recent research includes a RO1 NIH $2.3M grant to study long-term health habit formation. His publications span major economics journals like Econometrica and Review of Economic Studies , alongside medical journals such as JAMA Network Open . Scientific Awards: Sloan Research Fellowship (2010) IZA Young Labor Economist Award (2007) Barankay has held academic positions at the University of Essex and the University of Warwick prior to joining Wharton in 2008. He also serves as a Research Fellow at the Center for Economic and Policy Research (CEPR) and the Institute for the Study of Labor (IZA).

Peter Rothwellمشاهده پروفایل

استاد

• Stroke prevention
• Hypertension
• Aspirin therapy
• +۳ مورد دیگر

Peter Rothwell is the Action Research Professor of Neurology in the Nuffield Department of Clinical Neuroscience at the University of Oxford and a Professorial Fellow of St Edmund Hall. He serves as Head of the Centre for the Prevention of Stroke and Dementia and as an Honorary Consultant Neurologist for the Oxford University Hospitals Trust, maintaining active clinical practice in stroke prevention and general neurology. His educational background includes: MB ChB from the University of Edinburgh (1987) MD from the University of Edinburgh (1995) PhD from the University of Edinburgh (1999) FRCP from London (2002) FMedSci from the Academy of Medical Sciences (2008) Professor Rothwell's research centers on stroke prevention mechanisms , hypertension management , and aspirin's dual vascular/non-vascular effects , with significant contributions to understanding blood pressure variability and clinical trial translation. His work has redefined urgent stroke prevention protocols, particularly for transient ischemic attack patients. Recent publications (2024-2025) reveal three dominant trends: inflammatory biomarkers in stroke recurrence (e.g., interleukin-6/CRP studies), multimorbidity's impact on long-term outcomes, and innovative blood pressure interventions post-hemorrhage. His ASCOLT trial extends focus to aspirin's role in colorectal cancer prevention, demonstrating cross-disciplinary reach. Major recognitions include: British Medical Journal Award for Outstanding Clinical Research (2009) World Stroke Organisation Bienniel Award (2010) Kinmonth Medal, Royal College of Surgeons (2012) NIHR and Wellcome Trust Senior Investigator Awards He founded Oxford's Stroke Prevention Research Unit (2000), which has produced 25 doctorates and employs 30+ staff. Funded by Wellcome Trust, MRC, and Stroke Association, his work bridges laboratory research and clinical implementation through editorial roles in major journals and leadership in international trials like PROHIBIT-ICH. The unit operates within the Centre for the Prevention of Stroke and Dementia, conducting population-based cohort studies (OXVASC) and developing telemedicine solutions for home blood pressure monitoring, with direct impact on national stroke care pathways.

• Advanced Heart Failure
• Heart Transplantation
• Mechanical Circulatory Support
• +۲ مورد دیگر

Josef Stehlik, MD, MPH is a Professor of Medicine at the University of Utah School of Medicine . He serves as Medical Director of the Heart Transplant Program and Co-Chief of the Advanced Heart Failure Program at the University of Utah Hospital and Salt Lake City Veterans Affairs Medical Center . A Charles University graduate in medicine and holder of an MPH from Harvard School of Public Health , Dr. Stehlik has been on faculty since 2004. Education Charles University - MD Harvard School of Public Health - MPH Cleveland Clinic - Fellowship in Heart Failure and Transplantation Allegheny General Hospital - Residency in Internal Medicine and Cardiovascular Diseases Research Focus Dr. Stehlik's work centers on advanced heart failure , heart transplantation , and mechanical circulatory support . His research examines: Laboratory-based studies on donor-recipient matching and rejection mechanisms Clinical trials evaluating LVAD outcomes and device thrombosis Quality-of-life metrics in heart failure patients using wearable monitoring Policy impacts on organ allocation and transplant equity Comorbidities affecting post-transplant survival (e.g., diabetes, chronic kidney disease) Publication Trends His recent work explores: Optimization of donor-derived cell-free DNA assays for rejection detection Long-term implications of chronic kidney disease on malignancy risk post-transplantation Comparative effectiveness of LVADs like HeartMate 3 Public health analyses of obesity and waitlist outcomes Advancements in normothermic organ preservation

Bradi Bartrug Grangerمشاهده پروفایل

استاد پژوهشی

• Nursing Research
• Health Policy
• Cardiovascular Medicine
• +۵ مورد دیگر

Bradi Bartrug Granger is a Research Professor at Duke University School of Nursing, Director of the Duke Heart Center Nursing Research Program, and adjunct faculty at the University of Gothenburg. She holds core faculty status at the Duke-Margolis Center for Health Policy. With doctorate in nursing from the University of North Carolina at Chapel Hill, an MSN from Duke University, and a BSN from the University of Tennessee at Knoxville, her expertise spans implementation science, heart failure care, workforce stability, hypertension management, and health equity. 2004 - Ph.D., University of North Carolina at Chapel Hill 1991 - M.S.N., Duke University 1988 - B.S.N., University of Tennessee at Knoxville Her recent publications focus on nurse retention strategies, virtual reality rehabilitation for ICU patients, hypertension control in Black populations, and palliative care integration in heart failure management. Key grants include NIH/NINR-funded Nurse LEADS program (2024-2029), NSF research on XR rehabilitation games (2025-2027), and NHLBI-funded urine output tracking studies (2024-2026). She actively promotes evidence-based practice through clinical decision support tools and workforce analytics, maintaining affiliations with Duke's Science & Society initiative and Margolis Center for Health Policy.

Joshua T. Goldmanمشاهده پروفایل

دانشیار بالینی

• Concussion in Sports
• Pediatric Sports Medicine
• Training Load & Injury
• +۵ مورد دیگر

Dr. Joshua T. Goldman is a Clinical Associate Professor in both Family Medicine and Orthopaedic Surgery at the University of California, Los Angeles (UCLA) School of Medicine. Specializing in non-surgical orthopedic care and musculoskeletal ultrasound, he provides expert treatment for athletes and patients with musculoskeletal issues. Team physician for Los Angeles Chargers Team physician for UCLA Football, Men's Soccer, Women's Beach Volleyball Previous team physician roles: UCLA baseball, softball, women's water polo, men's volleyball, US Olympic Training Center Education MD - Keck School of Medicine of the University of Southern California (2010) Residency - Family Medicine, UCLA School of Medicine (2011-2013) Fellowship - Sports Medicine, UCLA School of Medicine (2014) MBA - University of Southern California Research Focus Dr. Goldman's research investigates critical areas in sports medicine including concussion management, pediatric sports medicine, training load optimization, sleep effects on athletic performance, and pediatric fracture treatment. His work bridges clinical practice with epidemiological studies on athlete safety. Scientific Contributions His publications analyze youth running safety, marathon training risks, cardiac complications in athletes, and advanced concussion assessment tools. He has developed consensus guidelines for youth running and pioneered ultrasound-guided interventions for tendon and joint conditions. Key studies on PRP and hyaluronic acid injections Concussion biomarker research Post-COVID athlete cardiac risks Medical disqualification protocols Professional Leadership Currently serving as: Associate Director, Orthopedic Institute for Children's Center for Sports Medicine Associate Director, UCLA Steve Tisch BrainSPORT Program Program Director, UCLA Sports Medicine Fellowship

• health services
• medical education
• medical informatics
• +۴ مورد دیگر

Dr. Robyn Tamblyn is a Professor in the Department of Medicine, Division of Clinical Epidemiology at McGill University's Faculty of Medicine and Health Sciences. She serves as a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) within the Cardiovascular Health Across the Lifespan Program and the Centre for Outcomes Research and Evaluation (CORE). Dr. Tamblyn's research focuses on conducting observational and interventional studies in public health and health services delivery aimed at improving healthcare safety and quality. Her work centers on identifying modifiable determinants of adverse events and improved health outcomes through analysis of large linked clinical and administrative databases. She leads a research team that develops and evaluates computer-enabled interventions to address modifiable risk factors, including computerized decision-support systems, personal health record portals, self-management tools, and automated surveillance systems. Analysis of Dr. Tamblyn's publication record reveals a strong emphasis on medication safety, pharmacoepidemiology, and healthcare informatics. Her research spans multiple domains including medication adherence, inappropriate prescribing, deprescribing interventions, medication reconciliation, and the use of electronic health records for pharmacosurveillance. A notable trend in her work is the development and evaluation of technology-enabled interventions to improve medication management and reduce adverse drug events across various healthcare settings. As a Senior Scientist at RI-MUHC, Dr. Tamblyn leads research initiatives within the Centre for Outcomes Research and Evaluation, focusing on healthcare quality improvement and patient safety. Her work bridges clinical medicine, epidemiology, and health informatics to address critical gaps in healthcare delivery systems. She collaborates extensively with clinicians, pharmacists, and health services researchers to implement evidence-based interventions that directly impact patient care.

Mohammad Aliمشاهده پروفایل

استادیار

• Computational Journalism
• Strategic Communication
• Trustworthy Artificial Intelligence
• +۵ مورد دیگر

Mohammad Ali is an Assistant Professor in the Department of Communication at the University of North Dakota. He holds dual PhDs in Information Studies from the University of Maryland, College Park, and Mass Communications from Syracuse University's S.I. Newhouse School of Public Communications. His research focuses on computational journalism, strategic communication, and trustworthy artificial intelligence with applications in natural language processing and media studies. Key research areas include: Computational Framing Analysis Fake News Detection Crisis Communication Visual Media Analysis Social Media Dynamics Recent publications demonstrate expertise in algorithmic approaches to media bias detection, strategic communication frameworks, and cross-cultural social media analysis. His work bridges technical NLP methods with practical communication theory applications. Collaborations span institutions including University of Maryland, Syracuse University, and Go Culture. Current projects involve large language models for misinformation identification and extended situational crisis communication theory incorporating visual elements.

• Geriatrics
• Fall Prevention
• Frailty Assessment
• +۳ مورد دیگر

Natalie A. Sanders is an Associate Professor of Clinical Internal Medicine in the Division of Geriatrics at the University of Utah, specializing in faint, fall, and frailty syndromes with expertise in delirium prevention. She serves as Program Director for the ACGME-approved Geriatric Fellowship and will assume Medical Directorship of the University of Utah Madsen Geriatrics Clinic in July 2023, while maintaining clinical practice at the University of Utah Geriatrics Clinic and leadership in the Hospital Elder Life Program (HELP). Her educational journey includes: B.S. in Biological Sciences from the University of Nevada D.O. from Western University of Health Sciences Internal Medicine Internship, Residency, and Geriatrics Fellowship at University of Utah School of Medicine (serving as Chief Medical Resident) Dr. Sanders' research centers on geriatric syndromes, investigating baroreceptor function in fall pathogenesis, testosterone-exercise interventions for fracture prevention, and prognostic value of frailty assessments. She actively disseminates the Patients Priority Care framework to align clinical practice with patient-centered goals, supporting the University of Utah's Age Friendly Health System accreditation through evidence-based approaches to elder care. Her publication record (2011-2019) demonstrates consistent focus on fall prevention, frailty assessment, and cardiovascular-geriatric interfaces, with significant contributions to clinic model innovation, cost analysis of specialized geriatric services, and educational frameworks for interdisciplinary care. These works collectively advance the understanding of multifactorial geriatric syndromes through rigorous clinical investigation and practical implementation science. Her professional recognition includes: Fellow of the American College of Physicians (FACP) Dr. Sanders mentors medical students, residents, and geriatric fellows while co-leading the Medicine-Geriatrics integrated residency/fellowship program. Her leadership extends to the pioneering University of Utah Faint and Fall Clinic (where she expanded frailty assessments as Medical Director) and the HELP program, both critical to the institution's national recognition in age-friendly care. Current initiatives focus on scaling Patients Priority Care implementation and refining fall prevention protocols through multidisciplinary collaboration across clinical and academic units. She directs clinical operations for geriatric services at the Madsen Health Center while contributing to national geriatric education through American Geriatrics Society curricula, maintaining active roles in both clinical innovation and training the next generation of geriatric specialists.

Colin Greavesمشاهده پروفایل

استاد

• Health Psychology
• Chronic Disease Prevention
• Behavioral Interventions
• +۷ مورد دیگر

Colin Greaves is a Chartered Health Psychologist and Professor of Psychology Applied to Health at the University of Birmingham. He specializes in developing and evaluating interventions for health behavior change, focusing on physical activity promotion, weight loss, smoking cessation, and chronic illness self-care. His work includes contributions to NICE and European diabetes prevention guidelines and a 5-year NIHR fellowship on weight loss maintenance. Academic Qualification: PhD in Psychology, University of Exeter (2003) Current funded research spans diabetes prevention (NDPS, ComPoD), heart failure self-management (REACH-HF), weight loss (SkiM), physical activity (REACT), and smoking cessation (TARS). His recent work emphasizes community-based trials, digital health applications, and co-designed interventions for musculoskeletal and post-bariatric care. Key Research Areas: Health behavior change interventions Chronic disease prevention Digital health tools (e.g., eMotion, Impulse Pal) Multimorbidity management Equity in healthcare access

Angelo P Tannaمشاهده پروفایل

استاد

• Glaucoma
• Ophthalmology
• Medical Imaging
• +۷ مورد دیگر

Angelo P Tanna, MD is Vice Chairman and Professor of Ophthalmology and Director of the Glaucoma Service at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. He has served on the faculty since 1999, establishing himself as a leading expert in glaucoma diagnosis and treatment. Dr. Tanna holds multiple leadership positions including Chair of the American Academy of Ophthalmology's Basic and Clinical Science Course Glaucoma Committee. Dr. Tanna's research interests span several critical areas in ophthalmology, with a primary focus on glaucoma. His work encompasses the efficacy and safety of glaucoma medications, detection of glaucoma progression, and assessment of visual function in glaucoma patients. He has made significant contributions to understanding the impact of cataract on visual field testing in glaucoma and has developed new methods to detect visual field deterioration. His research also includes improving outcomes of incisional glaucoma surgery and innovative approaches using hydrogel polymers to prevent fibrosis after trabeculectomy. Analysis of Dr. Tanna's recent publications reveals a strong emphasis on applying advanced technologies to glaucoma management, including deep learning algorithms for visual field progression detection using OCT imaging. His work increasingly explores social determinants of health in glaucoma care, healthcare access disparities, and the relationship between systemic conditions and ocular health. The COAST clinical trial he leads represents a significant contribution to optimizing laser trabeculoplasty protocols for glaucoma treatment. Secretariat Award, American Academy of Ophthalmology (2019) Senior Achievement Award, American Academy of Ophthalmology (2017) Continuously listed in Best Doctors in America since 2005 Outstanding Teacher Award, Northwestern University Feinberg School of Medicine (2020) Multiple visiting professorships at leading institutions including Columbia University (2023) Dr. Tanna has served in various leadership roles in the American Glaucoma Society, including twice as a board member and as Chair (2010-2011). He currently chairs the American Academy of Ophthalmology's Basic and Clinical Science Course Glaucoma Committee and serves on editorial boards of prestigious journals including Ophthalmology and Survey of Ophthalmology. His COAST clinical trial investigates optimal selective laser trabeculoplasty protocols for treating glaucoma, potentially reshaping treatment guidelines. Dr. Tanna also leads research collaborations with biomedical engineers and geneticists, resulting in discoveries such as the association of ANGPT1 region SNPs with primary open-angle glaucoma.

Carolyn S.P. Lamمشاهده پروفایل

استاد

• Heart Failure
• Cardiovascular Medicine
• Sex Differences in Cardiovascular Disease
• +۳ مورد دیگر

Dr. Carolyn S.P. Lam is a tenured Full Professor at Duke-National University of Singapore Medical School and Senior Consultant Cardiologist at National Heart Centre Singapore. She pioneered Singapore’s first Women’s Heart Clinic and co-founded Us2.ai, an AI-driven cardiovascular diagnostics startup. Academic Affiliation: Duke-National University of Singapore (Tenured Full Professor) Clinical Role: Senior Consultant Cardiologist at National Heart Centre Singapore Startup Leadership: Co-founder of Us2.ai, focusing on AI automation in echocardiography Her research focuses on heart failure with preserved ejection fraction (HFpEF), sex differences in cardiovascular disease, and clinical trial design. Key contributions include the PARAGON and EMPEROR-Preserved trials, leading to the first FDA-approved HFpEF treatment. She has published over 350 articles in top journals like NEJM, JAMA, and Lancet. Recent publications highlight her work on SGLT2 inhibitors, GLP-1 agonists, and mineralocorticoid receptor antagonists in heart failure. Thematic trends include pharmacological intervention , AI in diagnostics , and sex-specific medicine . Scientific Awards NMRC Senior Investigator Clinician Scientist Award Clarivate Highly Cited Researcher (2021, Clinical Medicine) Expertscape World Expert in Heart Failure 2021 ESC Guidelines Task Force Appointment International Honorary Fellow, Heart Failure Society of America (2021) As a mentor, she leads the ASIAN-HF multinational study across 11 Asian countries and served on global clinical trial executive committees. Her Us2.ai startup won the FedEx Small Business Grant Contest (2021) and Forbes Asia 100 to Watch (2020). She also contributes to public health education via the TV show Body and Soul and hosts the podcast Circulation On The Run .

Serge Korjianمشاهده پروفایل

عضو هیئت علمی

• Interventional Cardiology
• Clinical Trials
• Cardiovascular Research
• +۳ مورد دیگر

Dr. Serge Korjian is a prominent figure in clinical cardiology, currently serving as the Senior Medical Director of Clinical Trials and Director of the Angiographic Core Lab at the Baim Institute for Clinical Research. He is also an Instructor of Medicine at Harvard Medical School and an Attending Physician in Interventional Cardiology at Massachusetts General Hospital. His affiliations span leading institutions in cardiovascular research, including collaborations with Dr. C. Michael Gibson on international trials like APEX, AEGIS-I/II, PIONEER AF-PCI, and HEARTLINE. Dr. Korjian's research focuses on antiplatelet and anticoagulant therapies , lipid-modifying interventions , and novel devices for acute coronary syndromes . His expertise includes clinical trial design, protocol development, safety monitoring, and cardiovascular data analysis. Key contributions address residual risk in post-MI patients, cost-effectiveness of diagnostics, and bleeding prevention in AF-PCI cohorts. His recent publications highlight innovations in apolipoprotein A-I infusions , angiographic imaging , and risk prediction tools . Trends in his work emphasize patient-centric outcomes, digital trial recruitment, and the intersection of biomarkers (e.g., D-dimer, cholesterol efflux capacity) with clinical endpoints. While no formal scientific awards are disclosed in the text, his leadership in core labs and endpoint adjudication underscores his academic impact. Dr. Korjian's career bridges academic leadership with hands-on involvement in global clinical trials. He previously trained at the PERFUSE study group and Beth Israel Deaconess Medical Center , where he honed skills in interventional cardiology and statistical analysis. His current roles position him at the forefront of translational cardiovascular research and trial methodology.

• Computational Physiology
• Biomechanics
• Cardiac Electromechanics
• +۷ مورد دیگر

Joakim Sundnes is a Chief Research Scientist and Research Professor at the Department of Scientific Computing, Simula Research Laboratory. He specializes in computational physiology, cardiac biomechanics, and mathematical modeling of cardiovascular systems. Key Research Areas: Cardiac electromechanics, computational fluid dynamics in cardiology, uncertainty quantification in cardiac models, and mechano-electric feedback mechanisms Recent Trends: Focus on patient-specific modeling, left atrial flow dynamics, right ventricular mechanics in pulmonary hypertension, and personalized treatment simulations Scientific Contributions: Active participant in international conferences and editorial work. Co-author of multiple benchmark studies and educational texts on physiological modeling.